Syrup composition containing phage associated lytic enzymes
US7063837B2 · kind B2 · utility
9Cited by
94References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 19, 2001 |
| Grant date | Jun 20, 2006 |
| Priority date | — |
| Expiry date | Jul 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a method and composition for the treatment of bacterial infections by the parenteral introduction of at least one lytic enzyme produced by a bacteria infected with a bacteriophage specific for that bacteria and an appropriate carrier for delivering the lytic enzyme into a patient. The injection can be done intramuscularly, subcutaneously, or intravenously.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.